Patton Albertson Miller Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.22M | Buy |
11,831
+78
| +0.7% | +$6.96K | 0.12% | 112 |
|
|
2026
Q1 | $844K | Sell |
11,753
-100
| -0.8% | -$7.7K | 0.1% | 125 |
|
|
2025
Q4 | $941K | Buy |
11,853
+155
| +1% | +$12.2K | 0.11% | 124 |
|
|
2025
Q3 | $882K | Sell |
11,698
-5,530
| -32% | -$379K | 0.11% | 123 |
|
|
2025
Q2 | $1.19M | Buy |
17,228
+940
| +6% | +$61.6K | 0.16% | 105 |
|
|
2025
Q1 | $1.1M | Sell |
16,288
-2,187
| -12% | -$131K | 0.16% | 109 |
|
|
2024
Q4 | $829K | Sell |
18,475
-80,543
| -81% | -$4.52M | 0.11% | 123 |
|
|
2024
Q3 | $6.23M | Sell |
99,018
-4,737
| -5% | -$276K | 0.85% | 50 |
|
|
2024
Q2 | $6.13M | Buy |
103,755
+4,149
| +4% | +$260K | 0.87% | 48 |
|
|
2024
Q1 | $7.94M | Buy |
99,606
+9,609
| +11% | +$734K | 1.19% | 22 |
|
|
2023
Q4 | $7.11M | Buy |
89,997
+4,179
| +5% | +$297K | 1.19% | 22 |
|
|
2023
Q3 | $5.99M | Buy |
85,818
+63
| +0.1% | +$4.46K | 1.18% | 25 |
|
|
2023
Q2 | $5.93M | Sell |
85,755
-3,820
| -4% | -$272K | 1.15% | 21 |
|
|
2023
Q1 | $6.66M | Buy |
89,575
+1,913
| +2% | +$160K | 1.22% | 17 |
|
|
2022
Q4 | $8.17M | Sell |
87,662
-1,616
| -2% | -$156K | 1.5% | 11 |
|
|
2022
Q3 | $8.51M | Buy |
89,278
+4,328
| +5% | +$428K | 1.83% | 6 |
|
|
2022
Q2 | $7.87M | Buy |
84,950
+718
| +0.9% | +$70.1K | 1.61% | 6 |
|
|
2022
Q1 | $8.53M | Buy |
84,232
+1,853
| +2% | +$195K | 1.47% | 11 |
|
|
2021
Q4 | $8.5M | Buy |
82,379
+5,557
| +7% | +$514K | 1.37% | 12 |
|
|
2021
Q3 | $6.52M | Buy |
76,822
+33,200
| +76% | +$2.78M | 1.25% | 14 |
|
|
2021
Q2 | $3.64M | Buy |
43,622
+313
| +0.7% | +$25.6K | 0.83% | 36 |
|
|
2021
Q1 | $3.26M | Buy |
43,309
+964
| +2% | +$70.2K | 0.79% | 40 |
|
|
2020
Q4 | $2.99M | Buy |
42,345
+282
| +0.7% | +$18.3K | 0.71% | 45 |
|
|
2020
Q3 | $2.46M | Buy |
42,063
+938
| +2% | +$58.4K | 0.7% | 45 |
|
|
2020
Q2 | $2.67M | Buy |
41,125
+2,112
| +5% | +$133K | 0.78% | 38 |
|
|
2020
Q1 | $2.31M | Buy |
39,013
+1,173
| +3% | +$78.3K | 0.78% | 33 |
|
|
2019
Q4 | $2.81M | Buy |
37,840
+1,194
| +3% | +$83.8K | 0.74% | 34 |
|
|
2019
Q3 | $2.31M | Buy |
36,646
+442
| +1% | +$26.2K | 0.65% | 46 |
|
|
2019
Q2 | $2.15M | Buy |
36,204
+18,163
| +101% | +$978K | 0.62% | 53 |
|
|
2019
Q1 | $973K | Buy |
18,041
+4,755
| +36% | +$293K | 0.49% | 68 |
|
|
2018
Q4 | $865K | Sell |
13,286
-1,634
| -11% | -$122K | 0.46% | 62 |
|
|
2018
Q3 | $1.04M | Sell |
14,920
-385
| -3% | -$27.5K | 0.53% | 64 |
|
|
2018
Q2 | $985K | Buy |
15,305
+1,743
| +13% | +$115K | 0.5% | 68 |
|
|
2018
Q1 | $844K | Buy |
13,562
+204
| +2% | +$14.6K | 0.38% | 75 |
|
|
2017
Q4 | $968K | Sell |
13,358
-8,824
| -40% | -$642K | 0.39% | 73 |
|
|
2017
Q3 | $1.79M | Sell |
22,182
-2,865
| -11% | -$227K | 0.78% | 38 |
|
|
2017
Q2 | $2M | Sell |
25,047
-2,679
| -10% | -$212K | 0.89% | 26 |
|
|
2017
Q1 | $2.25M | Sell |
27,726
-312
| -1% | -$24.9K | 0.93% | 25 |
|
|
2016
Q4 | $2.21M | Sell |
28,038
-1,112
| -4% | -$90K | 0.95% | 25 |
|
|
2016
Q3 | $2.59M | Sell |
29,150
-1,937
| -6% | -$183K | 1.14% | 19 |
|
|
2016
Q2 | $2.98M | Sell |
31,087
-1,620
| -5% | -$161K | 1.33% | 16 |
|
|
2016
Q1 | $3.39M | Sell |
32,707
-701
| -2% | -$68.2K | 1.71% | 13 |
|
|
2015
Q4 | $3.27M | Buy |
33,408
+45
| +0.1% | +$4.41K | 1.64% | 11 |
|
|
2015
Q3 | $3.22M | Sell |
33,363
-2,813
| -8% | -$296K | 1.71% | 9 |
|
|
2015
Q2 | $3.79M | Buy |
36,176
+396
| +1% | +$40.5K | 1.66% | 6 |
|
|
2015
Q1 | $3.69M | Buy |
35,780
+6,962
| +24% | +$704K | 1.5% | 9 |
|
|
2014
Q4 | $2.77M | Buy |
28,818
+10,717
| +59% | +$944K | 1.29% | 20 |
|
|
2014
Q3 | $1.45M | Buy |
18,101
+3,810
| +27% | +$300K | 0.76% | 37 |
|
|
2014
Q2 | $1.08M | Buy |
14,291
+6,520
| +84% | +$493K | 0.55% | 59 |
|
|
2014
Q1 | $582K | Buy |
+7,771
| New | +$549K | 0.31% | 85 |
|
Other funds holding CVS
Patton Albertson Miller Group's CVS Position: Q2 2026 in Review
Patton Albertson Miller Group increased its CVS Health (CVS) stake by 0.66% in Q2 2026, buying an estimated $6.96K and bringing the position to 11,831 shares worth $1.22M. The position accounts for 0.12% of the portfolio, ranked #112.
Patton Albertson Miller Group first reported a position in CVS in Q1 2014 and has held it in 50 quarters since. The position peaked at $8.53M in Q1 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Patton Albertson Miller Group held 11,831 shares of CVS Health worth $1.22M as of Q2 2026.
- Patton Albertson Miller Group bought 78 CVS Health shares in Q2 2026, an estimated $6.96K.
- CVS Health made up 0.12% of Patton Albertson Miller Group's portfolio in Q2 2026, its #112 holding.
- Patton Albertson Miller Group first reported a position in CVS Health in Q1 2014 and has held it in 50 quarters since.
- Patton Albertson Miller Group's CVS Health position peaked at $8.53M in Q1 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Patton Albertson Miller Group's 13F filing for Q2 2026, filed 22 Jul 2026.